The FTIR has a detection limit of approximately 5%. Substances below this level may not appear in results — even if they are toxic or affect the potency of your sample.
When possible, we may provide a percentage estimate based on what the FTIR detects. These numbers are generated by software and reflect only the visible components — not the full composition of the sample. The FTIR cannot isolate individual substances in complex mixtures, so any percentage estimates are approximate. They may not reflect actual potency, and similar-looking samples can yield different results – therefore we do not provide purity testing. Any percentages we offer are estimates based on the visible ingredients identified through FTIR spectroscopy. Since this method does not account for the entire sample, undetected ingredients below the detection threshold may influence the composition. The percentages are intended only as a general indication of how the identified ingredients are distributed within the sample. Due to this, any percentages provided cannot be used to calculate milligram quantities within a sample. Our results should not be used to determine exact dosages.
Additionally, a sample may not reflect the full composition of a drug. For example, testing part of a pill may not represent the rest. Cross-contamination between samples stored together can also affect results.
When we detect only one substance, we don’t provide a percentage because other ingredients might still be present below the 5% detection limit.
Treat any percentage result as a rough guideline, not a precise measurement.
Tests highlighted in red indicate particularly dangerous or unexpected results. Flagged samples can alslo be viewed on our Alerts page.
We also use test strips to detect the presence of fentanyl, benzodiazapenes, and lysergamide (LSD).
The results provided are strictly for personal use and educational purposes. They must not be published, distributed, or shared publicly in any form. Unauthorized sharing, reproduction, or publication of these results is strictly prohibited and may result in disciplinary action.
If you find our results shared elsewhere, please be aware that such use is unauthorized and we do not condone it. Images or representations of our results can be easily replicated or altered online, potentially containing misleading or false information. We strongly recommend testing your own samples to ensure accuracy and reliability.
This sample has similarities to a number of steroids, and is likely a steroid not in our libraries. This finding can not be confirmed. Methyltestosterone is in our libraries.
Prince George, BC
03/09/2024
Category: Unknown White Pressed Pill
Unknown
Microcrystalline Cellulose
50-55%
Calcium Stearate
15-20%
Stanozolol
10-15%
Uncertain Mineral
5-10%
Uncertain Match
5-10%
Fentanyl: Negative
Vancouver, BC
03/09/2024
Category: Other White Powder Code: Helion
Trestolone Acetate
Trestolone Acetate
90-95%
Uncertain Match
5-10%
Fentanyl: Negative
Prince George, BC
03/09/2024
Category: Other White Powder Code: Helion
Mesterolone
Mesterolone
Fentanyl: Negative
Prince George, BC
03/09/2024
Category: Other White Powder Code: Helion
Tamoxifen
Tamoxifen
80-85%
Uncertain Match
15-20%
Fentanyl: Negative
This sample was submitted as tamoxifen citrate, confirmed as tamoxifen citrate.
Prince George, BC
03/09/2024
Category: Unknown White Powder
Unknown
Microcrystalline Cellulose
80-85%
Calcium Stearate
10-15%
Lisdexamfetamine
5-10%
Fentanyl: Negative Benzodiazepine: Negative
Lisdexamfetamine dimesylate, sold under the brand name Vyvanse, belongs to the group of medicines called central nervous system (CNS) stimulants. It is used to treat attention deficit hyperactivity disorder in children and adults, and for moderate-to-severe binge eating disorder in adults. Common side effects include nausea/ vomiting, stomach/abdominal pain, loss of appetite, dry mouth, headache, dizziness, restlessness, weight loss, and irritability.